Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-09-26
2006-09-26
Russel, Jeffrey Edwin (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S331000
Reexamination Certificate
active
07112570
ABSTRACT:
The invention relates to GPE analogs, particularly GPE analogs capable of inducing an equivalent physiological effect to GPE within a patient. Such GPE analogs include peptides where the Gly of Gly-Pro-Glu is replaced by any of Ala, Ser, Thr, or Pro; where the Pro of Gly-Pro-Glu is replaced by any of Ala, Ser, Thr, or Gly; and where the Glu of Gly-Pro-Glu is replaced by any of Asn, Asp, or Gln. The GPE analogs of the invention have application in any method of therapy or prophylaxis in which GPE has application. These applications include the treatment of acute brain injury and neurodegenerative disease, including but not limited to injury or disease in the CNS. The GPE analogs will normally be administered as part of a pharmaceutical composition or preparation.
REFERENCES:
patent: 4906614 (1990-03-01), Giertz et al.
patent: 5750376 (1998-05-01), Weiss et al.
patent: 5853695 (1998-12-01), Srivastava et al.
patent: 5965536 (1999-10-01), Cohen et al.
patent: 5965603 (1999-10-01), Johnson et al.
patent: 6310093 (2001-10-01), Newcomb
patent: 6342585 (2002-01-01), Grossman
patent: 0366 638 (1990-05-01), None
patent: 0 357 240 (1993-01-01), None
patent: 2 707 170 (1995-01-01), None
patent: WO 91/19006 (1991-12-01), None
patent: WO 93/08828 (1993-05-01), None
patent: WO 93/21216 (1993-10-01), None
patent: WO 94/23754 (1994-10-01), None
patent: WO 95/17204 (1995-06-01), None
patent: WO 96/40871 (1996-12-01), None
patent: WO 97/00688 (1997-01-01), None
patent: WO 97/17090 (1997-05-01), None
patent: WO 97/47735 (1997-12-01), None
patent: WO 98/16242 (1998-04-01), None
patent: WO 00/13650 (2000-03-01), None
Alexi Tajrena
Gluckman Peter
Fliesler & Meyer LLP
Neuren Pharmaceuticals Ltd.
Russel Jeffrey Edwin
LandOfFree
GPE analogs does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with GPE analogs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and GPE analogs will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3593239